The role of vaccines in preventing bacterial antimicrobial resistance

Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries

(2017) Robert Cohen et al.   Expert Review of Vaccines

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design

(2017) Emma Rey-Jurado et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing

(2017) Zhong Peng et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

(2017) Angela Huttner et al.   LANCET INFECTIOUS DISEASES

A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail

(2017) Debra A Goff et al.   LANCET INFECTIOUS DISEASES

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

(2017) Mark H. Wilcox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

(2017) Robert W. Frenck et al.   VACCINE

A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential

(2017) Timothy F. Landers et al.   PUBLIC HEALTH REPORTS

Escherichia coli Harboringmcr-1andblaCTX-Mon a Novel IncF Plasmid: First Report ofmcr-1in the United States

(2016) Patrick McGann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol

(2016) Julia Simioni et al.   BMC Pediatrics

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

(2016) Sara Tomczyk et al.   CLINICAL INFECTIOUS DISEASES

Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention

(2016) Gustavo H. Dayan et al.   Expert Review of Vaccines

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011

(2016) Katherine E. Fleming-Dutra et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion

(2016) Marian L. Gaviola et al.   PHARMACOTHERAPY

Siderophore vaccine conjugates protect against uropathogenicEscherichia coliurinary tract infection

(2016) Laura A. Mike et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

(2016) Geert Leroux-Roels et al.   VACCINE

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults

(2016) Eric Sheldon et al.   VACCINE

Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models

(2016) Germie P.J.M. van den Dobbelsteen et al.   VACCINE

Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers

(2016) Nicole Bézay et al.   VACCINE

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial

(2016) Guy de Bruyn et al.   VACCINE

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?

(2016) Marc Lipsitch et al.   mBio

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study

(2016) Matthew R Moore et al.   Lancet Respiratory Medicine

One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A

(2016) Francesca Mancini et al.   PLoS One

The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis

(2015) John C. Kash et al.   AMERICAN JOURNAL OF PATHOLOGY

Extraintestinal PathogenicEscherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

(2015) Jan T. Poolman et al.   JOURNAL OF INFECTIOUS DISEASES

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

(2015) Joan O. Ngwuta et al.   Science Translational Medicine

Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response

(2015) Leire Aguinagalde et al.   PLoS One

Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status

(2014) Gonçalo Matias et al.   Influenza and Other Respiratory Viruses

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

(2014)   PEDIATRICS

The contribution of vaccination to global health: past, present and future

(2014) B. Greenwood   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

(2014) Stefan H E Kaufmann et al.   Lancet Respiratory Medicine

Intrawound Vancomycin Powder Reduces Surgical Site Infections in Posterior Cervical Fusion

(2013) Cyrus Caroom et al.   SPINE

Vaccines against gonorrhea: Current status and future challenges

(2013) Ann E. Jerse et al.   VACCINE

Identification and characterization of antigens as vaccine candidates againstKlebsiella pneumoniae

(2013) Urban Lundberg et al.   Human Vaccines & Immunotherapeutics

Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008

(2012) Hong Zhou et al.   CLINICAL INFECTIOUS DISEASES

Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults

(2012) Kyle Widmer et al.   JOURNAL OF INFECTIOUS DISEASES

Scaling up interventions to achieve global tuberculosis control: progress and new developments

(2012) Mario Raviglione et al.   LANCET

Emergence and global spread of epidemic healthcare-associated Clostridium difficile

(2012) Miao He et al.   NATURE GENETICS

Effect of a Best-Practice Alert on the Rate of Influenza Vaccination of Pregnant Women

(2012) Timothy E. Klatt et al.   OBSTETRICS AND GYNECOLOGY

Adherence to Surgical Care Improvement Project Measures and Post-Operative Surgical Site Infections

(2012) Samir S. Awad   Surgical Infections

Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae

(2011) Thomas Tängdén et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines

(2011) L. M. Hampton et al.   JOURNAL OF INFECTIOUS DISEASES

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

(2011) Timothy R Walsh et al.   LANCET INFECTIOUS DISEASES

Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

(2010) Charles F von Reyn et al.   AIDS

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Invasive group B streptococcal disease in an orthopaedic unit

(2010) P.J. Jenkins et al.   JOURNAL OF HOSPITAL INFECTION

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination

(2010) H.J. Adam et al.   VACCINE

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

(2010) Inci Yildirim et al.   VACCINE

Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India

(2009) D. Yong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effect of Universal Influenza Immunization on Antibiotic Prescriptions: An Ecological Study

(2009) Jeffrey C. Kwong et al.   CLINICAL INFECTIOUS DISEASES

Staphylococcal Vaccines and Immunotherapies

(2009) Adam C. Schaffer et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Staphylococcus aureusantigens and challenges in vaccine development

(2008) John R Middleton   Expert Review of Vaccines

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals

(2008) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES